CD8A and neoplasm: Recent studies also demonstrated that itaconate derived from myeloid-derived suppressor cells (MDSCs) promoted tumor growth by inhibiting T cell cytotoxic function or inducing CD8 + T cell exhaustion in hepatocellular carcinoma (Gu et al, 2023; Zhao et al, 2022).